Literature DB >> 15713123

Nitric oxide and blood: a review.

J P Wallis1.   

Abstract

Nitric oxide (NO) was identified as a physiological mediator of vascular tone in 1987. NO produced by endothelial cells causes vasodilatation and also inhibits platelet aggregation and leucocyte adhesion. Red cells metabolize NO to nitrate but may possibly carry and release, or even produce, NO in hypoxic conditions. NO physiology may have important implications for transfusion medicine, ranging from adverse effects of haemoglobin substitutes to preservation of stored platelets and to detrimental effects of stored red cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713123     DOI: 10.1111/j.1365-3148.2005.00542.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  17 in total

Review 1.  Haemoglobin-based oxygen carriers: research and reality towards an alternative to blood transfusions.

Authors:  Andrea Mozzarelli; Luca Ronda; Serena Faggiano; Stefano Bettati; Stefano Bruno
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  Recommendations for the transfusion of red blood cells.

Authors:  Giancarlo Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

3.  Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

4.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

Review 5.  Examining and mitigating acellular hemoglobin vasoactivity.

Authors:  Pedro Cabrales
Journal:  Antioxid Redox Signal       Date:  2012-10-11       Impact factor: 8.401

6.  Improving Blood Compatibility of Intravascular Oxygen Sensors Via Catalytic Decomposition of S-Nitrosothiols to Generate Nitric Oxide In Situ.

Authors:  Yiduo Wu; Alvaro P Rojas; Grant W Griffith; Amy M Skrzypchak; Nathan Lafayette; Robert H Bartlett; Mark E Meyerhoff
Journal:  Sens Actuators B Chem       Date:  2007-01-30       Impact factor: 7.460

7.  Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.

Authors:  Roxana Mehran; Stuart J Pocock; Gregg W Stone; Tim C Clayton; George D Dangas; Frederick Feit; Steven V Manoukian; Eugenia Nikolsky; Alexandra J Lansky; Ajay Kirtane; Harvey D White; Antonio Colombo; James H Ware; Jeffrey W Moses; E Magnus Ohman
Journal:  Eur Heart J       Date:  2009-04-07       Impact factor: 29.983

Review 8.  Nitric oxide-releasing/generating polymers for the development of implantable chemical sensors with enhanced biocompatibility.

Authors:  Yiduo Wu; Mark E Meyerhoff
Journal:  Talanta       Date:  2007-06-28       Impact factor: 6.057

9.  Long-term nitric oxide release and elevated temperature stability with S-nitroso-N-acetylpenicillamine (SNAP)-doped Elast-eon E2As polymer.

Authors:  Elizabeth J Brisbois; Hitesh Handa; Terry C Major; Robert H Bartlett; Mark E Meyerhoff
Journal:  Biomaterials       Date:  2013-06-15       Impact factor: 12.479

10.  Nitric oxide-releasing S-nitrosothiol-modified xerogels.

Authors:  Daniel A Riccio; Kevin P Dobmeier; Evan M Hetrick; Benjamin J Privett; Heather S Paul; Mark H Schoenfisch
Journal:  Biomaterials       Date:  2009-06-06       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.